C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction

Circulation

Volumn 96, Issue 3, 1997, Pages 778-784

  Anzai, Toshihisa ^a,b   Yoshikawa, Tsutomu ^a   Shiraki, Hiroto ^a   Asakura, Yasushi ^a   Akaishi, Makoto ^a   Mitamura, Hideo ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aneurysm; Infarction; myocardial; Proteins

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART DEATH; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ANEURYSM; HEART RUPTURE; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030855262     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.3.778     Document Type: Article

References (45)

1. Mundth E. Rupture of the heart complicating myocardial infarction. Circulation. 1972;46:427-429.
2. Bates R, Beutler S, Resnekov L, Anagnostopoulos CE. Cardiac rupture: challenge in diagnosis and management. Am J Cardiol. 1977;40:429-437.
3. Saffitz JE, Fredrickson RC, Roberts WC. Relation of size of transmural acute myocardial infarct to mode of death, interval between infarction and death and frequency of coronary arterial thrombus. Am J Cardiol. 1986;57:1249-1254.
4. Dellborg M, Held P, Swedeberg K, Vedin A. Rupture of the myocardium: occurrence and risk factors. Br Heart J. 1985;54:11-16.
5. Batts KP, Ackermann DM, Edwards WD. Postinfarction rupture of the left ventricular free wall: clinicopathologic correlates in 100 consecutive autopsy cases. Hum Pathol. 1990;21:530-535.
6. Mann JM, Roberts WC. Rupture of the left ventricular free wall during acute myocardial infarction: analysis of 138 necropsy patients and comparison with 50 necropsy patients with acute myocardial infarction without rupture. Am J Cardiol. 1986;62:847-859.
7. Pohjola-Sintonen S, Muller JE, Stone PH, Willich SN, Antman EM, Davis VG, Parker CB, Braunwald E. Ventricular septal and free wall rupture complicating AMI: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J. 1989;117: 809-818.
8. Shapira I, Isakov A, Burke M, Almog C. Cardiac rupture in patients with acute myocardial infarction. Chest. 1987;92:219-223.
9. Schuster EH, Bulkley BH. Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture. Circulation. 1979;60:1532-1538.
10. Jugdutt BI, Michorowski BL. Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction: a two-dimensional echocardiographic study. Clin Cardiol. 1987;10: 641-652.
11. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
12. Hammerman H, Kloner RA, Hale F, Schoen FJ, Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation and ventricular function. Circulation. 1983;68:446-452.
13. Hammerman H, Kloner RA, Schoen FJ, Brown EJ Jr, Hale S, Braunwald E. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation. 1983;67:1290-1295.
14. Brown EJ Jr, Kloner RA, Schoen FJ, Hammerman H, Hale S, Braunwald E. Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol. 1983;51: 877-883.
15. Silverman HS, Pfeifer MP. Relation between use of anti-inflammatory agents in left ventricular free wall rupture during acute myocardial infarction. Am J Cardiol. 1987;59:363-364.
16. Pepys MB. C-reactive protein fifty years on. Lancet. 1981;1: 653-656.
17. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, Shimada K. Serum interleukin 6 level becomes elevated in acute myocardial infarction. J Mol Cell Cardiol. 1992; 24:579-584.
18. Harper RW, Kennedy G, DeSanctis RW, Hutter AM. The incidence of angina prior to acute myocardial infarction. Am Heart J. 1979;97:178-183.
19. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med. 1992;153:154-183.
20. WHO Study Group. Diabetes mellitus. World Health Organ Tech Rep Ser. 1985;727:7-98.
21. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. Am J Cardiol. 1967;20:457-464.
22. Forrester JS, Diamond G, Chatterjee K, Swan HJC. Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med. 1976;295:1356-1362.
23. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon D, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Circulation. 1975; 51:5-40.
24. The TIMI Study Group. The thrombolysis in myocardial infarction trial. N Engl J Med. 1985;312:932-936.
25. Kasser IS, Kennedy JW. Measurement of left ventricular volumes in man by single-plane cineangiocardiography. Invest Radiol. 1969; 4:83-90.
26. Meizlish JL, Berger HJ, Plankey M, Errico D, Levy W, Zaret BL. Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction. N Engl J Med. 1984;311: 1001-1006.
27. Voulgari F, Cummins P, Gardecki TI, Beeching NJ, Stone PC, Stuart J. Serum level of acute phase and cardiac proteins after myocardial infarction, surgery, and infection. Br Heart J. 1982;48: 352-356.
28. Gram J, Kluft C, Jespersen J. Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction. Thromb Haemost. 1987;58:817-821.
29. Mollnes TE, Tambs KE, Myreng Y, Engebresten LF. Acute phase reactants and complement activation in patients with acute myocardial infarction. Complement. 1988;5:33-39.
30. Haq M, Haq S, Tutt P, Crook M. Serum total sialic acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins. Ann Clin Biochem. 1993;30:383-386.
31. Dinarello CA. Interleukin-6 and the pathogenesis of the acute-phase response. N Engl J Med. 1984;311:1413-1418.
32. Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E. Elevated plasma interleukin-6 level in patients with acute myocardial infarction. Am Heart J. 1993;126:1299-1304.
33. de Beer FC, Hind CRK, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J. 1982;47:239-243.
34. Pietilä K, Harmonien A, Teppo AM. Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator. Ann Med. 1991;23:529-535.
35. Pietilä K, Harmoinen A, Hermens W, Simoons ML, Van de Werf F, Verstraete M. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J. 1993;14:915-919.
36. Vatner SF, Baig H, Manders WT, Maroko PR. Effects of coronary reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest. 1978;61:1048-1056.
37. Anzai T, Yoshikawa T, Asakura Y, Abe M, Meguro T, Akaishi M, Mitamura H, Handa S, Ogawa S. Effect on short-term prognosis and left ventricular function of angina pectoris prior to first Q-wave anterior wall acute myocardial infarction. Am J Cardiol. 1994;74: 755-759.
38. Anzai T, Yoshikawa T, Asakura Y, Abe S, Akaishi M, Mitamura H, Handa S, Ogawa S. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol. 1995;26:319-327.
39. Pietilä K, Harmoinen A, Pöyhönen L, Rousteenoja R. C-reactive protein in subendocardial and transmural myocardial infarcts. Clin Chem. 1986;32:1596-1597.
40. Richard V, Murry CE, Reimer KA. Healing of myocardial infarcts in dogs: effect of late reperfusion. Circulation. 1995;92:1891-1901.
41. Ross RM, Young JA. Clinical and necropsy findings in rupture of the myocardium: a review of forty-three cases. Scott Med J. 1963; 8:222-226.
42. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med. 1979; 300:57-62.
43. Crook M, Haq M, Haq S, Tutt P. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology. 1994;45: 709-715.
44. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
45. Zardini P, Marino P, Golia G, Anselmi M, Castelli M. Ventricular remodeling and infarct expansion. Am J Cardiol. 1993;72: 98G-106G.